118 related articles for article (PubMed ID: 35403225)
1. Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial.
Granfeldt A; Andersen LW; Vallentin MF; Hilberg O; Hasselstrøm JB; Sørensen LK; Mogensen S; Christensen S; Grejs AM; Rasmussen BS; Kristiansen KT; Strøm T; Johansen IS; Schjørring OL; Simonsen U
Acta Anaesthesiol Scand; 2022 Aug; 66(7):838-846. PubMed ID: 35403225
[TBL] [Abstract][Full Text] [Related]
2. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
Barrett CD; Moore HB; Moore EE; Wang J; Hajizadeh N; Biffl WL; Lottenberg L; Patel PR; Truitt MS; McIntyre RC; Bull TM; Ammons LA; Ghasabyan A; Chandler J; Douglas IS; Schmidt EP; Moore PK; Wright FL; Ramdeo R; Borrego R; Rueda M; Dhupa A; McCaul DS; Dandan T; Sarkar PK; Khan B; Sreevidya C; McDaniel C; Grossman Verner HM; Pearcy C; Anez-Bustillos L; Baedorf-Kassis EN; Jhunjhunwala R; Shaefi S; Capers K; Banner-Goodspeed V; Talmor DS; Sauaia A; Yaffe MB
Chest; 2022 Mar; 161(3):710-727. PubMed ID: 34592318
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
5. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
6. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
[TBL] [Abstract][Full Text] [Related]
7. Treatment with senicapoc, a K
Petersen AG; Lind PC; Mogensen S; Jensen AB; Granfeldt A; Simonsen U
Br J Pharmacol; 2022 May; 179(10):2175-2192. PubMed ID: 34623632
[TBL] [Abstract][Full Text] [Related]
8. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Bosteels C; Maes B; Van Damme K; De Leeuw E; Declercq J; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):491. PubMed ID: 32503663
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
10. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.
Bracegirdle L; Jackson A; Beecham R; Burova M; Hunter E; Hamilton LG; Pandya D; Morden C; Grocott MPW; Cumpstey A; Dushianthan A;
PLoS One; 2022; 17(6):e0269471. PubMed ID: 35687543
[TBL] [Abstract][Full Text] [Related]
11. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
12. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
13. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19.
Sonti R; Pike CW; Cobb N
J Intensive Care Med; 2021 Mar; 36(3):327-333. PubMed ID: 33234007
[TBL] [Abstract][Full Text] [Related]
15. Response to the first awake prone positioning relates with intubation rate in SARS-CoV-2 patients suffering from acute respiratory failure with moderate to severe hypoxaemia: a retrospective study.
Lupieri E; Boffi A; Ltaief Z; Schneider A; Abed-Maillard S; Chiche JD; Oddo M; Piquilloud L
Swiss Med Wkly; 2022 Aug; 152():w30212. PubMed ID: 36102065
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a "Pandemic Ready" Intensive Care Unit - Lessons from Singapore.
Chew SY; Lee YS; Ghimiray D; Tan CK; Chua GS
Ann Acad Med Singap; 2020 Jul; 49(7):434-448. PubMed ID: 33000106
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
[TBL] [Abstract][Full Text] [Related]
18. Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
Azoulay E; Lemiale V; Mokart D; Nseir S; Argaud L; Pène F; Kontar L; Bruneel F; Klouche K; Barbier F; Reignier J; Berrahil-Meksen L; Louis G; Constantin JM; Mayaux J; Wallet F; Kouatchet A; Peigne V; Théodose I; Perez P; Girault C; Jaber S; Oziel J; Nyunga M; Terzi N; Bouadma L; Lebert C; Lautrette A; Bigé N; Raphalen JH; Papazian L; Darmon M; Chevret S; Demoule A
JAMA; 2018 Nov; 320(20):2099-2107. PubMed ID: 30357270
[TBL] [Abstract][Full Text] [Related]
19. Early prolonged prone position in noninvasively ventilated patients with SARS-CoV-2-related moderate-to-severe hypoxemic respiratory failure: clinical outcomes and mechanisms for treatment response in the PRO-NIV study.
Musso G; Taliano C; Molinaro F; Fonti C; Veliaj D; Torti D; Paschetta E; Castagna E; Carbone G; Laudari L; Aseglio C; Zocca E; Chioni S; Giannone LC; Arabia F; Deiana C; Benato FM; Druetta M; Campagnola G; Borsari M; Mucci M; Rubatto T; Peyronel M; Tirabassi G
Crit Care; 2022 Apr; 26(1):118. PubMed ID: 35488356
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
